Zai Lab (ZLAB) Interest Coverage Ratio (2018 - 2026)
Zai Lab (ZLAB) posted Interest Coverage Ratio of 42.39 for Q1 2026, down 1200.16% sequentially from 3.26 in Q4 2025, and up 10.65% YoY from 38.3 in Q1 2025.
Zai Lab (ZLAB) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Zai Lab has reported Interest Coverage Ratio for 9 years, with the latest figure at 42.39 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 10.65% year-over-year to 42.39 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.48 (up 87.6% YoY) and the FY2025 annual result came in at 0.53, up 25.19% from the prior year.
- Interest Coverage Ratio retreated to 42.39 in Q1 2026 per ZLAB's latest filing, from 3.26 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.34 in Q4 2022 and troughed at 622.2 in Q1 2024.
- A 5-year average of 101.41 and a median of 43.5 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio slumped 3785.31% in 2023, then surged 94.79% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 0.34 in 2022, then plunged by 3785.31% to 13.31 in 2023, then sank by 370.22% to 62.57 in 2024, then soared by 94.79% to 3.26 in 2025, then plunged by 1200.16% to 42.39 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 42.39, 3.26, and 34.87 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | -48.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.20 |
| Mar 31, 2026 | -42.39 |
| Dec 31, 2025 | -3.26 |
| Sep 30, 2025 | -34.87 |
| Jun 30, 2025 | -43.50 |
| Mar 31, 2025 | -47.44 |
| Dec 31, 2024 | -62.57 |
| Sep 30, 2024 | -91.08 |
| Jun 30, 2024 | -154.60 |
| Mar 31, 2024 | -622.20 |
| Dec 31, 2023 | -13.31 |
| Dec 31, 2022 | -0.34 |
| Dec 31, 2021 | -1.16 |
| Dec 31, 2020 | -3,969.00 |
| Sep 30, 2020 | -1,773.42 |
| Jun 30, 2020 | -0.13 |
| Mar 31, 2020 | -691.37 |
| Dec 31, 2019 | -20.30 |
| Sep 30, 2019 | -853.26 |
| Dec 31, 2018 | -47.11 |